Index

A

algorithm, 174, 180–182

Allen Human Brain Atlas

(AHBA), 212

Alzheimer’s disease (AD), 8, 49,

174, 185, 205, 209, 240,

257

AD modeling, 51

amyloid precursor protein, 49

clinical manifestations, 8

clinical trials in AD, 52

connectome, 240

diagnosis, 8

DSM, 8

NINCDSADRDA, 8

memory, 8

microarray studies, 205

MSCs in AD, 53

neurofibrillary tangles, 49

NSCs in AD, 54

PSCs in AD, 50

RNA-seq studies, 209

tau, 49

treatment, 9

amyotrophic lateral sclerosis

(ALS), 15, 58, 206, 209

ALS modeling, 58

biomarkers, 16

clinical manifestations, 16

clinical trials in ALS, 59

diagnosis, 15

fALS-related genes, 58

familial ALS, 15

microarray studies, 206

MSCs in ALS, 59

NSCs in ALS, 59

PSCs in ALS, 58

RNA-seq studies, 209

treatment, 16

artificial intelligence (AI), 179,

182, 185, 213

attention deficit hyperactivity

disorder (ADHD), 22,

208, 212

microarray studies, 208

RNA-seq studies, 212

autism, 24

autism spectrum disorder (ASD),

24, 208, 211

microarray studies, 208

RNA-seq studies, 211

treatment, 25

autistic, 24

B

BCI paradigms

motor imagery (MI), 177,

179, 182, 185

P300-based BCI speller, 179

steady-state visual evoked

potential (SSVEP), 179

betweenness centrality, 229

Bioconductor

DESeq2, 203

EdgeR, 203

LIMMA, 203

normalization techniques, 203

R Programming, 203

Robust Multi-array Average

(RMA), 203

bioinformatics, 164, 198

artificial intelligence, 213

273